Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM

Diabetes Care

Volumn 19, Issue 9, 1996, Pages 945-952

  Torlone, Elisabetta ^a   Pampanelli, Simone ^a   Lalli, Carlo ^a   Del Sindaco, Paola ^a   Di Vincenzo, Antonio ^a   Rambotti, Anna Maria ^a   Modarelli, Francesco ^a   Epifano, Lucilla ^a   Kassi, Giorgia ^a   Perriello, Gabriele ^a   Brunetti, Paolo ^a   Bolli, Geremia ^a,b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; INSULIN; INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 9544243821     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.9.945     Document Type: Article

References (21)

1. Di Marchi RD, Mayer JP, Fan L: Synthesis of a fast-acting insulin based on structural homology with insulin-like growth factor 1. In Peptides: Chemistry and Biology: Proieedings of the Twelfth American Peptide Symposium. Smith HA, Rivier JE, Eds. Leiden, Netherlands, ESCOM, p. 26-28
2. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)l human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
3. Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, Di Vincenzo A, Epifano L, Ciofetta M, Pampanelli S, Brunetti P, Bolli GB: Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM. Diabetologia 37:713-720, 1994
4. Tuominen JA, Karonen S-L, Melamies L, Bolli G, Koivisto VA: Exercise-induced hypoglycaemia in IDDM patients treated with a short-acting insulin analogue. Diabetologia 38:106-111, 1995
5. Pampanelli S, Torlone E, Lalli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB: Improved post-prandial metabolic control after subcutaneous injection of a short-acting insulin analogue in IDDM of short duration with residual pancreatic B-cell function. Diabetes Care 18:1452-1459, 1995
6. Anderson JH, Brunelle R, Vignati L: Insulin Lispro compared to regular insulin in a crossover study involving 1037 patients with type I diabetes. Diabetes 44 (Suppl. 1):228A, 1995
7. Nielsen FS, Jorgensen LN, Ipsen M, Voldsgaard AI, Parving H-H: Long-term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen. DiabeTologia 38:592-598, 1995
8. Fanelli C, Pampanelli S, Epifano L, Rambotti AM, De Vincenzo A, Modarelli F, Ciofetta M, Lepore M, Annibale B, Torlone E, Perriello G, De Feo P, Santeusanio F, Brunetti P, Bolli GB: Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, after institution of rational, intensive insulin therapy in IDDM. Diabetologia 37:1265-1276, 1994
9. McGuire E, Helderman J, Tobin R, Andres R, Berman M: Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 41:565-573, 1976
10. De Feo P, Perriello G, Ventura VM, Calcinaro F, Basta G, Lolli C, Cruciani C, Dell'Olio A, Santeusanio F, Brunetti P, Bolli GB: Studies on overnight insulin requirements and metabolic clearance rate of insulin in normal and diabetic man: relevance to the pathogenesis of the dawn phenomenon. Diabetologia 29:475-480, 1986
11. Fanelli C, De Feo P, Porcellati F, Perriello G, Torlone E, Santeusanio F, Brunetti P, Bolli GB: Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis. J Clin Invest 89: 2005-2013, 1992
12. Perriello G, Torlone E, Di Santo S, Fanelli C, De Feo P, Santeusanio F, Brunetti P, Bolli GB: Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 diabetes mellitus. Diabetologia 31: 811-815, 1988
13. Zar J: Biostatistical Analysis. Englewood Cliffs, NJ, Prentice Hall, 1984
14. Dimitriadis G, Gerich J: Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus. Diabetes Care 6:374-377, 1983
15. Heinemann L, Heise T, Wahl LCh, Trautmann ME, ArnpudiaJ, Starke AAR, Berger M: Prandial glycaemia after a carbohydrate-rich meal in type 1 diabetic patients: using the rapid acting insulin analogue [Lys (B28), Pro (B29)] human insulin. Diabetic Med 13:625-629, 1996
16. Binder C, Lauritzen T, Faber O, Pramrning S: Insulin pharmacokinetics. Diabetes Care 7:188-199, 1984
17. Bolli GB: The pharmacokinetic basis of insulin therapy. Diabetes Res Clin Pract 6:S3-S16, 1989
18. Dimitriadis G, Gerich J: Effect of a twice daily subcutaneous administration of a long-acting somatostatin analog on 24-hour plasma glucose profiles in patients with insulin-dependent diabetes mellitus. Horm Metab Res 10:510-511, 1985
19. Heine RJ, Bilo HJ, Fonk T, Van der Veen EA, Van der Meer J: Absorption kinetics and action profiles of mixtures of short-and intermediate-acting insulins. Diabetologia 27:558-562, 1984
20. Bilo HJ, Heine RJ, Sikkenk AC, Van der Meer J, Van Der Veen EA: Absorption kinetics and action profiles of intermediate acting human insulins. Diabetes Res 4:39-43, 1987
21. Hubinger A, Weber W, Jung W, Wehmeyer K, Gries FA: The pharmacokinetics of two different concentrations of short-acting insulin, intermediate-acting insulin, and an insulin mixture following subcutaneous injection. Clin Pharmacol 70: 621-626, 1992